Alocasia tissue culture: what the published protocols use

Eighteen shoots per explant. That is the number a lab manager will see first in the published micropropagation work on Alocasia longiloba, and it is the number most likely to be misread. It belongs to one treatment, in one study, on one genotype, at one stage of culture — not to a production cycle, and not to the named Alocasia clones that move through the ornamental trade.

This is a reference piece rather than news: there is no announcement here, only what the literature actually states for anyone weighing up whether to take the crop on.

Alocasia longiloba

What the study reports

The study is Abdulhafiz and colleagues, published in Plants (Basel) on 29 June 2020 (9(7):816) and open access through PMC. The species is Alocasia longiloba Miq, known locally as keladi candik in Kelantan, Malaysia. The explant is seed: the authors write that earlier micropropagation of A. longiloba, by Bhatt et al., used rhizomes as starting material, and that to the best of their knowledge no study had used seed.

The figures the paper states, all of them for that genotype under its own conditions:

Seed tested with tetrazolium chloride salt showed 89% viability.

Germination was poor untreated; seeds treated with 30% sulfuric acid gave maximum germination of 87% after 19.00 d, while gibberellic acid gave a maximum of 53% after 22 d.

For shoot multiplication the authors screened cytokinins alone and in combination with auxin, and BAP alone performed best: 3 mg L−1 BAP gave the highest shoot length, 7.26 cm, and the maximum number of shoots per explant, 18.

For in vitro rooting, indole-3-acetic acid at 0.5 mg L−1 was the optimum concentration.

For callus induction, 3 mg L−1 IAA gave the highest callus percentage, 91, and fresh weight of 6 g.

For acclimatization, topsoil and peat moss at a 1:2 ratio was the best soil medium of those tested.

The second half of the paper is an assay comparison rather than a propagation result. The in vitro-derived callus extract showed the highest phenolic content at 538 mg GAE, ahead of field-grown fruit and petiole at 504 and 300 mg GAE, with the in vitro plant extract lowest at 98 mg GAE. On DPPH radical scavenging the callus extract gave an IC50 of 0.113 mg mL−1, with petiole, fruit and in vitro plant at 0.126, 0.137 and 0.173 mg mL−1; on ABTS the fruit extract gave the best value among those tested, an IC50 of 0.088 mg mL−1. Those are assay readings in that paper, nothing more.

What the full methods add

The methods are more complete than the abstract suggests. Cultures ran on MS medium with 30 g L−1 sucrose and 2.78 g L−1 Gelrite, at 25 ± 2 °C under a 16-h photoperiod. Seeds were washed under running tap water for 30 min and surface-sterilized in Clorox (5.25% sodium hypochlorite) at 10, 20, 30 or 40%, with a few drops of Tween-20.

The sterilization table is the part a lab will want. At 10% Clorox, 62.50% of cultures were contaminated and 32.50% of seeds survived. At 30%, contamination fell to 16.66% and survival rose to 79.66%. At 40%, contamination was 5.83% and survival 78.66%, and the authors note that the 30% and 40% survival figures did not differ significantly.

Two more figures the abstract leaves out: the in vitro plants were subcultured every four weeks, and after six weeks of acclimatization the plantlets survived at a rate of 97%.

What the paper still does not give you is a production rate. Its 18 shoots per explant is a four-week count for one treatment, not a rate sustained across successive subcultures, and there is nothing about cost, labor or yield per vessel.

The 30% sulfuric acid scarification is the study's own procedure, with its own handling context in the paper. It is not a bench shortcut to lift out of context, and concentrated acid is a hazard class many ornamental labs do not stock or train for.

What it means for a lab costing the crop

Start with what the explant choice decides for you. Seed gives a seedling population, not a clone. A protocol built from seed establishes the species in culture; it does not deliver trueness to type for a named cultivar, which is what most buyers of ornamental Alocasia are paying for. If your order book says a clone, the relevant line in this paper is the one citing Bhatt et al. on rhizomes as starting material — vegetative explants — and that is a different protocol with its own contamination profile.

Second, treat 3 mg L−1 BAP as a starting point for your own trials, not as a setting. The response is the authors' for A. longiloba seedling material; Alocasia in the trade spans several species and many selections, and cytokinin optima are not transferable between them by assumption. The honest use of this paper is to narrow a screen — BAP alone before BAP plus auxin — and to log what your own material does.

Third, the callus work is a different business from plant production. A callus line producing 538 mg GAE of phenolic content is a biomass proposition aimed at extract buyers; the study compared extracts rather than reporting regenerated, trueness-tested plants from that callus. A plant lab reading this paper for multiplication can set the callus section aside.

Where the reasoning stops: you cannot build a cost per plantlet from this paper. It gives a subculture interval and an acclimatization survival rate, but no multiplication rate sustained across cycles, no loss figure at transfer and no labor data, so any bench-to-sale model you build on it is your assumption wearing someone else's numbers. What you can build is a trial plan with defined comparisons — explant type, one cytokinin at three concentrations, your own contamination and acclimation counts recorded per batch — which is exactly the record a second protocol decision needs.

Verify this

Before you quote a multiplication rate

If a supplier or a protocol cites a shoots-per-explant figure, ask three things: which species and genotype, at which stage, and over how many subculture cycles. A single-stage count from a screening trial and a sustained per-cycle rate in production are different numbers, and only one of them belongs in a costing.

Where to read the primary literature

The A. longiloba study is free to read in full: Micropropagation of Alocasia longiloba Miq and Comparative Antioxidant Properties of Ethanolic Extracts of the Field-Grown Plant, In Vitro Propagated and In Vitro-Derived Callus, on PMC.

A second open-access paper, published in Horticultura Brasileira and titled In vitro propagation of five Alocasia species, is on SciELO. Its results are not summarized here; a lab comparing species responses should read it directly and check which species, explants and media it covers before treating anything in it as applicable.

The open question is the one neither paper was written to answer: what Alocasia costs per saleable plantlet in a commercial lab, once losses at every transfer, labor and a sustained multiplication rate are counted. This paper reports initiation contamination and acclimatization survival for one species grown from seed; the full production picture is not in the published record, and growers are left reading optimization trials as if they were production data.